Pharmaceutical companies are developing ways to adopt omnichannel communication practices – and there are some industry-specific caveats. Planning and executing a proper campaign in life sciences means you have to transplant the vast knowledge from other industries (like customer journey building) into a new context while also dealing with content.
How to gain this knowledge?
On April 28 at 4:00 PM CET, industry experts got together at Next Normal to discuss the interconnection between omnichannel campaigning in pharma and the innovative modular content approach: splitting content into flexible reusable blocks that are MLR-preapproved and channel-agnostic.
Agenda:
- Building an omnichannel campaign in practice: prerequisites, insights, goals
- Findings from actual projects, and the role of personalized content
- Why content personalization involves standardization “backstage”
- How modular approach can be used as a key to unlock omnichannel for the industry
Speakers:
1. Nataliya Andreychuk – Chief Executive Officer at Viseven
2. Pavel Klymenko – Head of Omnichannel / Multichannel Excellence at Viseven
3. José Ma. Guido Avila – Customer Engagement Transformation Lead at Sanofi
4. Romika Bhowmick – Associate Director Commercial Platforms Strategy at Teva
